# TODO

### Dataset Todo
- [ ] Add "synthetic" data #13 [nice-to-have]
- [ ] Run ChemDataExtractor on Free Text #18 [needs-discussion] 
- [ ] Prepare PubChem dataset #19 [priority-high]
- [ ] Add CheMBL dataset #24 [priority-high]
- [ ] Add ESOL dataset #33 [priority-high]

### Dataset In Progress
- [ ] Add Drug-Target Interaction data #68 [strubeyj]
- [ ] H2_storage_materials_database #64 [bethanyconnolly]  
- [ ] Add chebi-20 dataset #63 [jackapbutler]  
- [ ] Add EuroPMC Dataset #32 [abhinav-kashyap-asus]  
- [ ] contribution guide specify the following #69[kjappelbaum]
- [ ] Add Therapeutic Data Commons dataset #27 [priority-high]
  -[ ] Single-instance
    - [ ] Add Drug-Target Interaction data #68
    - [ ] Add ADME Property
      - [ ] Absorption
          - [x] Caco-2 (Cell Effective Permeability), Wang et al. []
          - [x] PAMPA Permeability, NCATS []
          - [ ] HIA (Human Intestinal Absorption), Hou et al.
          - [ ] Pgp (P-glycoprotein) Inhibition, Broccatelli et al.
          - [ ] Bioavailability, Ma et al.
          - [x] Lipophilicity, AstraZeneca []
          - [ ] Solubility, AqSolDB
          - [ ] Hydration Free Energy, FreeSolv
      - [ ] Distribution
          - [ ] BBB (Blood-Brain Barrier), Martins et al.
          - [ ] PPBR (Plasma Protein Binding Rate), AstraZeneca
          - [ ] VDss (Volumn of Distribution at steady state), Lombardo et al.
      - [ ] Metabolism
          - [ ] CYP P450 2C19 Inhibition, Veith et al.
          - [ ] CYP P450 2D6 Inhibition, Veith et al.
          - [ ] CYP P450 3A4 Inhibition, Veith et al.
          - [ ] CYP P450 1A2 Inhibition, Veith et al.
          - [ ] CYP P450 2C9 Inhibition, Veith et al.
          - [ ] CYP2C9 Substrate, Carbon-Mangels et al.
          - [ ] CYP2D6 Substrate, Carbon-Mangels et al.
          - [ ] CYP3A4 Substrate, Carbon-Mangels et al.
      - [ ] Excretion
          - [ ] Half Life, Obach et al.
          - [ ] Clearance, AstraZeneca
    - [ ] Add Toxicity [phalem]
      - [x] Acute Toxicity LD50
      - [ ] hERG blockers
      - [ ] hERG Central
      - [ ] hERG Karim et al.
      - [ ] Ames Mutagenicity
      - [ ] DILI (Drug Induced Liver Injury)
      - [ ] Skin Reaction
      - [ ] Carcinogens
      - [ ] Tox21
      - [ ] ToxCast
      - [x] ClinTox
    - [ ] Add High-throughput Screening [phalem]
        - [ ] SARS-CoV-2 In Vitro, Touret et al.
        - [ ] SARS-CoV-2 3CL Protease, Diamond.
        - [ ] HIV
        - [x] Butkiewicz et al.
    - [ ] Add Quantum Mechanics Modeling []
      - [ ] QM7b
      - [ ] QM8
      - [ ] QM9
    - [ ] Add Reaction Yields []
      - [ ] Buchwald-Hartwig
      - [ ] USPTO
    - [ ] Add Epitope(Immunotherapy under Target discovery)[strubeyj]
      - [ ] IEDB, Jespersen et al.
      - [ ] PDB, Jespersen et al.
    - [ ] Add Antibody Developability
      - [ ] TAP
      - [ ] SAbDab, Chen et al.
    - [ ] Add CRISPR Repair Outcome
      - [ ] Leenay et al.

  -[ ] Multi-instance
    - [ ] Add Drug-Target Interaction data #68[strubeyj]
      - [ ] BindingDB
      - [ ] DAVIS
      - [ ] KIBA
    - [ ] Add Drug-Drug Interaction
      - [ ] DrugBank Multi-Typed DDI
      - [ ] TWOSIDES Polypharmacy Side Effects
    - [ ] Add Gene-Disease Association
      - [ ] DisGeNET
    - [ ] Add Drug Response
      - [ ] GDSC1
      - [ ] GDSC2
    - [ ] Add Peptide-MHC Binding
      - [ ] MHC Class I, IEDB-IMGT, Nielsen et al.
      - [ ] MHC Class II, IEDB, Jensen et al.
    - [ ] Add Antibody-antigen Affinity 
      - [ ] SAbDab
    - [ ] Add MicroRNA-Target Interaction
      - [ ] miRTarBase
    - [ ] Add Catalyst
      - [ ] USPTO
    - [ ] Add TCR-Epitope Binding Affinity
      - [ ] Weber et al.
 
  -[ ] Generation data
    - [ ] Add Molecule Generation
      - [ ] MOSES
      - [ ] ZINC
      - [ ] ChEMBL
    - [ ] Add Retrosynthesis
      - [ ] USPTO-50K
      - [ ] USPTO
    - [ ] Add Reaction Outcome
      - [ ] USPTO
    - [ ] Add Structure-based Drug Design 
      - [ ] PDBBind
      - [ ] DUD-E
      - [ ] scPDB

### Done âœ“
- [x] Add flashpoint dataset #43 [othertea]
